These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1859091)

  • 1. Phospholipase A2 as a "death trigger" in the aging process. The use of PLA2 inhibitors as antiaging substances.
    Regelson W; Franson R
    Ann N Y Acad Sci; 1991; 621():262-76. PubMed ID: 1859091
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism(s) of cytoprotective and anti-inflammatory activity of PGB1 oligomers: PGBx has potent anti-phospholipase A2 and anti-oxidant activity.
    Franson RC; Rosenthal MD; Regelson W
    Prostaglandins Leukot Essent Fatty Acids; 1991 Jun; 43(2):63-70. PubMed ID: 1886908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligomers of prostaglandin B1 inhibit in vitro phospholipase A2 activity.
    Franson RC; Rosenthal MD
    Biochim Biophys Acta; 1989 Dec; 1006(3):272-7. PubMed ID: 2597672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of human sperm phospholipase A2 in fertilization: effects of a novel inhibitor of phospholipase A2 activity on membrane perturbations and oocyte penetration.
    Fry MR; Ghosh SS; East JM; Franson RC
    Biol Reprod; 1992 Nov; 47(5):751-9. PubMed ID: 1477202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of the phospholipase A2 inhibitors aristolochic acid and PGBx on A23187-stimulated mobilization of arachidonate in human neutrophils are overcome by diacylglycerol or phorbol ester.
    Rosenthal MD; Lattanzio KS; Franson RC
    Biochim Biophys Acta; 1992 Jun; 1126(3):319-26. PubMed ID: 1322178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligomers of prostaglandin B1 inhibit arachidonic acid mobilization in human neutrophils and endothelial cells.
    Rosenthal MD; Franson RC
    Biochim Biophys Acta; 1989 Dec; 1006(3):278-86. PubMed ID: 2557075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial recovery after ischemia: in vivo effects of PGBX, a polymeric derivative of PGB1.
    Angelakos ET; West R; Wudarski E
    Adv Prostaglandin Thromboxane Res; 1980; 7():671-3. PubMed ID: 6768229
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions between PGBx and disophenol in the isolated perfused rat heart.
    Aronson CE
    Gen Pharmacol; 1981; 12(4):249-53. PubMed ID: 7250675
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of PGBx on glucose utilization and glycogen content of the isolated rat diaphragm.
    Aronson CE
    Gen Pharmacol; 1983; 14(5):519-23. PubMed ID: 6642192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a direct inhibitory effect of glucocorticoids on the activity of phospholipase A2 as a further possible mechanism of some actions of steroidal anti-inflammatory drugs.
    Mentz P; Giessler C; Förster W
    Pharmacol Res Commun; 1980 Sep; 12(8):817-27. PubMed ID: 7443764
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the incorporation of [1-14C]arachidonic acid into glycerolipids and its conversion into prostaglandins by rabbit iris. Effects of anti-inflammatory drugs and phospholipase A2 inhibitors.
    Abdel-Latif AA; Smith JP
    Biochim Biophys Acta; 1982 Jun; 711(3):478-89. PubMed ID: 6809058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug.
    Okimasu E; Moromizato Y; Watanabe S; Sasaki J; Shiraishi N; Morimoto YM; Miyahara M; Utsumi K
    Acta Med Okayama; 1983 Oct; 37(5):385-91. PubMed ID: 6689106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinflammatory effects of phospholipase A2 (PLA2) in several in vitro and in vivo systems.
    Chang J; Marshall LM; Carlson RP
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():594-7. PubMed ID: 2526543
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of antirheumatic drugs for their effect in vitro on purified human synovial fluid phospholipase A2.
    Marshall LA; Bauer J; Sung ML; Chang JY
    J Rheumatol; 1991 Jan; 18(1):59-65. PubMed ID: 2023201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Simultaneous and sequential inhibition of the arachidonic acid cascade by inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases in carrageenan edema and adjuvant arthritis in the rat].
    Bekemeier H; Hirschelmann R; Ramanampison ML; Pantović D
    Pharmazie; 1986 Jun; 41(6):406-8. PubMed ID: 3094043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory phospholipase A2 inhibitors. Possible new anti-inflammatory agents.
    Tanaka K; Arita H
    Agents Actions Suppl; 1995; 46():51-64. PubMed ID: 7610991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phospholipase A2 inhibitors].
    Tanaka K; Arita H; Inoue K
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1987-99. PubMed ID: 8210439
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative evaluation of the effect of prostaglandins E1, A1, B1 and F2-alpha on systemic and regional hemodynamics].
    Buniatian AA; Muratov VK; Flerov EV; Ismailov ShI
    Akush Ginekol (Mosk); 1979 Jan; (1):13-7. PubMed ID: 434342
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of a human, endogenous, phospholipase A2 inhibitory, antiinflammatory protein.
    Longenecker JP; Rose JW; Giffin K; Shepard D; Johnson LK
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():581-6. PubMed ID: 2959117
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of type I and type II phospholipase A2 by phosphatidyl-ethanolamine linked to polymeric carriers.
    Dan P; Dagan A; Krimsky M; Pruzanski W; Vadas P; Yedgar S
    Biochemistry; 1998 Apr; 37(17):6199-204. PubMed ID: 9558359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.